United States: WilmerHale Advises Aushon BioSystems In $6.14M Series C Financing
Last Updated: July 29 2016

Aushon BioSystems, a global provider of protein biomarker measurement and analysis products and services via an innovative, cost-effective multiplex immunoassay platform that delivers exceptional performance with industry-leading ease-of-use, announced that it held the initial closing of a $6.14 million Series C Financing.

With a growing menu of more than 300 biomarkers in key therapeutic areas and advanced microarray printing technology, Aushon BioSystems' comprehensive suite of products and services offers a complete solution for customers—global leaders in the pharmaceutical, biotechnology, academic and diagnostic industries.

The WilmerHale team was led by Partner Mick Bain and included Senior Associate Stephanie Singer and Associate Jared Iverson.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Press Releases from this Firm
Recent Content from this Firm
By Michael Connor, H. David Gold, Sarah Judkins, Andrew L. Spielman
By Lester Ross, Tingting Liu
By H. David Gold, Rachel Jacobson, Heidi K. Ruckriegle
By Joseph Mueller, Thomas Saunders, Leslie Pearlson
By WilmerHale
By Robert D. Burke, A. William Caporizzo, Julie Hogan Rodgers, Meghan Walsh
By WilmerHale
By Jamie Gorelick, William McLucas, Bruce M. Berman, Danielle Conley, Tania Faransso
By Ambassador Charlene Barshefsky, Naboth van den Broek, David Ross, Patrick J. McLain, David Horn
By David Gammell
Font Size: